Synthesis, characterization and anticancer studies of mixed ligand dithiocarbamate palladium(II) complexes

European Journal of Medicinal Chemistry

Volumn 46, Issue 9, 2011, Pages 4071-4077

  Khan, Hizbullah ^a,b,c   Badshah, Amin ^b   Murtaz, Ghulam ^b   Said, Muhammad ^b   Rehman, Zia Ur ^b   Neuhausen, Christine ^d   Todorova, Margarita ^e   Jean Claude, Bertrand J ^e   Butler, Ian S ^a  

^a MCGILL UNIVERSITY   (Canada)

^b QUAID I AZAM UNIVERSITY   (Pakistan)

^c UNIVERSITY OF MALAKAND   (Pakistan)

^d EPFL   (Switzerland)

^e ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Crystal structure; Dithiocarbamate; DU145; Mixed ligand; Palladium(II)

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BENZYLDIPHENYLPHOSPHINE; BIS(2 METHOXYETHYL)DITHIOCARBAMATE; CARBOPLATIN; CISPLATIN; DICYCLOHEXYLDITHIOCARBAMATE; DIETHYLDITHIOCARBAMIC ACID; DIMETHYLDITHIOCARBAMATE SODIUM; DIPHENYL 2 METHOXYPHENYLPHOSPHINE; DIPHENYL 2 PYRIDYLPHOSPHINE; DIPHENYL 3 TOLYLPHOSPHINE; DIPHENYL 4 TOLYLPHOSPHINE; DITHIOCARBAMIC ACID DERIVATIVE; LOBAPLATIN; NEDAPLATIN; PALLADIUM COMPLEX; TRICYCLOHEXYLPHOSPHINE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CRYSTAL STRUCTURE; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; INFRARED SPECTROSCOPY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROSTATE CANCER; PROTON NUCLEAR MAGNETIC RESONANCE; RAMAN SPECTROMETRY; X RAY DIFFRACTION;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CRYSTALLOGRAPHY, X-RAY; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INHIBITORY CONCENTRATION 50; LIGANDS; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; PALLADIUM; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SPECTRUM ANALYSIS, RAMAN; THIOCARBAMATES;

EID: 80052950320     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2011.06.007     Document Type: Article

References (37)

1. M. Shaharyar, M.M. Abdullah, M.A. Bakht, and J. Majeed Eur. J. Med. Chem. 45 2010 114 119
2. American Cancer Society, in American Cancer Society Statistics For 2007, http://www.cancer.org/docroot/PRO/content/PRO-1-1-Cancer-Statistics-2007- Presentation.asp.
3. R. Palchaudhuri, V. Nesterenko, and P.J. Hergenrother J. Am. Chem. Soc. 130 2008 10274 10281
4. K.S. Lovejoy, and S.J. Lippard Dalton Trans. 48 2009 10651 10659
5. Y. Kasherman, S. Sturup, and D. Gibson J. Med. Chem. 52 2009 4319 4328
6. T. Tsubomura, M. Ogawa, S. Yano, K. Kobayashi, T. Sakurai, and S. Yoshikawa Inorg. Chem. 29 1990 2622 2626
7. J.D. Aguirre, A.M.A. Boza, A. Chouai, J.P. Pellois, C. Turro, and K.R. Dunbar J. Am. Chem. Soc. 131 2009 11353 11360
8. J. Gao, Y.G. Liu, and R.A. Zingaro Chem. Res. Toxicol. 22 2009 1705 1712
9. Z. Xue, M. Lin, J. Zhu, J. Zhang, Y. Lia, and Z. Guo Chem. Commun. 46 2010 1212 1214
10. T. Boulikas, and M. Vougiouka Oncol. Rep. 10 2003 1663 1682
11. E. Wong, and C.M. Giandomenico Chem. Rev. 99 1999 2451 2466
12. M. Galanski, V.B. Arion, M.A. Jakupec, and B.K. Keppler Curr. Pharm. Des 9 2003 2078 2089
13. T. Tanaka, K. Yukawa, and N. Umesaki Oncol. Rep. 14 2005 1365 1369
14. D. Wang, and S.J. Lippard Nat. Rev. Drug Discov. 4 2005 307 320
15. S.J. Berners-Price, and T.G. Appleton L.R. Kelland, N. Farrell, Platinum-based Drugs in Cancer Therapy 2000 Humana Press Totowa, NJ 3 31
16. Y. Jung, and S.J. Lippard Chem. Rev. 107 2007 1387 1407
17. J.K. Barnham, M.I. Djuran, P.S. Murdoch, J.D. Ranford, and P.J. Sadler Inorg. Chem. 35 1996 1065 1072
18. T. Rau, and R. Van Eldik A. Sigel, H. Sigel, Metal Ions in Biological Systems vol. 31 1996 M. Dekker New York 339 378
19. W. Micklitz, W.S. Sheldrick, and B. Lippert Inorg. Chem. 29 1990 211 216
20. K.J. Barnham, C.J. Bauer, M.I. Djuran, M.A. Mazid, T. Rau, and P.J. Sadler Inorg. Chem. 34 1995 2826 2832
21. W.Z. Shen, D. Gupta, and B. Lippert Inorg. Chem. 44 2005 8249 8258
22. E.J. Gao, F.C. Liu, M.C. Zhu, L. Wang, Y. Huang, H.Y. Liu, S. Ma, Q.Z. Shi, and N. Wang Enzym. Inhib. Med. Chem. 25 2010 1 8
23. E.J. Gao, L. Wang, M.C. Zhu, L. Liu, and W.Z. Zhang Eur. J. Med. Chem. 45 2010 311 316
24. B. Elzbieta, M. Magdalena, L. Ingo-Peter, M. Peter, A.K. Renata, P. Piotr, K. Urszula, and R.J. Marek Inorg. Chem. 45 2006 9688 9695
25. H.A. Ewais, M. Taha, and H.N. Salm J. Chem. Eng. Data 55 2010 754 758
26. M.P. Hacker, E.B. Douple, and I.H. Krakoff M.A. Nijhoff, Platinum Coordination Complexes in Cancer Chemotherapy 1984 267 Boston
27. V. Alverdi, L. Giovagnini, C. Marzano, R. Seraglia, F. Bettio, R. S.SitranGraziani, and D. Fregona J. Inorg. Biochem. 98 2004 1117 1128
28. G. Hogarth, E.J.C. Richards, C.R. Rainford-Brent, S.E. Kabir, I. Richards, J.D.E.T. Wilton-Ely, and Q. Zhang Inorg. Chim. Acta 362 2009 2020 2026
29. D.L. Bodenner, P.C. Dedon, P.C. Keng, and R. Borch Cancer Res. 46 1986 2745 2750
30. J.J. Criado, J.A.L. Aria, B. Marcias, and L.R.F. Lago Inorg. Chim. Acta 193 1992 229 233
31. M. Castillo, J.J. Criado, B. Marcias, and M.V. Vaquero Inorg. Chim. Acta 124 1986 127 132
32. F. Shaheen, A. Badshah, M. Gielen, G. Croce, U. Florke, D.D. Vos, and S. Ali J. Organomet. Chem. 695 2010 315 322
33. F.H. Allen, O. Kennard, D.G. Watson, L. Brammer, A.G. Orpen, and R. Taylor J. Chem. Soc. Perkin Trans. 2 1987 S1 S19
34. R.M.C. Cattaneo-Pangrazzi, H. Schott, and R.A. Schwendener The Prostate 45 2000 8 18
35. X. Area, Stoe, and Cie Darmstadt 2006
36. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J.T. Warren, H. Bokesch, S. Kenney, and Michael R. Boyd J. Natl. Cancer Inst. 82 1990 1107 1112
37. A. Rahman, M.I. Choudhary, and W.J. Thomsen In Bioassay Techniques for Drug Development 2001 Harward Academic Press Amsterdam